Billerica, Massachusetts, United States Bruker BioSpin appeared to be the Corporate Investor, which was created in 1975. The leading representative office of defined Corporate Investor is situated in the Billerica. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 10 participants. The meaningful sponsors for the fund in investment in the same round are TaKaRa Shuzo, Perseus-Soros Biopharmaceutical Fund, OrbiMed.
The important activity for fund was in 2001. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there is Biotechnology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight GeneFormatics.
Related Funds
| Fund Name | Location |
| AdMaster | China, Shanghai |
| Center of Aging and Brain Health Innovation | Canada, Ontario, Toronto |
| Essential Capital | Beijing, China, Haidian |
| Gegnum | North, Portugal, São João da Madeira |
| Horizon Holding Group | - |
| Kyoto University Innovation Capital | Japan, Kyoto, Kyoto Prefecture |
| Life Science Angels | California, Sunnyvale, United States |
| MegaThrust Capital Berhad | - |
| NEO Investment Partners | England, London, United Kingdom |
| Nooky Box | - |
| SAC | China, Guangdong, Shenzhen |
| Shanghai Hua Hong International | - |
| Startup Holding | Latvia, Riga, Vidzeme |
| Two Sigma Private Investments | - |
| TZP Group | New York, New York, United States |
| Washington Post | District of Columbia, United States, Washington |
| Wolff Center for Entrepreneurship | Houston, Texas, United States |
| Yamato Shinkin | Japan, Nara Prefecture, Sakurai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 